267 related articles for article (PubMed ID: 8842332)
1. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the endothelium-independent and endothelium-dependent contraction in isolated canine cerebral arteries.
Kanda M; Shirahase H; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1996 Jul; 46(7):663-6. PubMed ID: 8842332
[TBL] [Abstract][Full Text] [Related]
2. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries.
Kanda M; Shirahase H; Kurahashi K; Wada K; Nakamura S; Matsui H; Fukata F
Arzneimittelforschung; 1995 Aug; 45(8):831-5. PubMed ID: 7575741
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effect of the new dihydropyridine calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl methyl 4-(2-fluoro-5-nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedica rbo xylate hydrochloride in dogs.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Apr; 42(4):513-8. PubMed ID: 1642675
[TBL] [Abstract][Full Text] [Related]
5. Effects of the new long-acting dihydropyridine calcium antagonist pranidipine on the endothelium-dependent relaxation in isolated rat aorta in vitro.
Nakayama N; Ikezono K; Ohura M; Yabuuchi Y
Arzneimittelforschung; 1993 Dec; 43(12):1266-70. PubMed ID: 8141812
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological studies on a new Dihydrothienopyridine calcium antagonist. 2nd communication: effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4- (3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate on the 1,4-dihydropyridine binding sites in the brain and on isolated arteries in the Cynomolgus monkey.
Nakajima M; Adachi I; Ueda M
Arzneimittelforschung; 1993 Dec; 43(12):1276-82. PubMed ID: 8141814
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
[TBL] [Abstract][Full Text] [Related]
8. Effect of accumulation of NKY-722, a water-soluble vasoselective Ca++ antagonist, on KCl-induced contraction in isolated canine mesenteric arteries.
Shimaji H; Shirahase H; Kanda M; Osumi S; Kurahashi K
J Pharmacol Exp Ther; 1991 Aug; 258(2):676-80. PubMed ID: 1865364
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
Tsuchida K; Yamazaki R; Kaneko K; Aihara H
Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effect of NKY-722, a new water-soluble 1,4-dihydropyridine derivative, on conscious spontaneously hypertensive rats.
Osumi S; Morishita S; Wada K; Usui H; Kanda M; Matsui H; Kakeya N
Tohoku J Exp Med; 1988 Jun; 155(2):205-6. PubMed ID: 3212781
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of the calcium antagonist NKY-722 against renal and arterial injuries in Dahl salt-sensitive rats.
Shirahase H; Uehara Y; Wada K; Shimaji H; Ishimitsu T; Hashizume Y; Kanda M; Nakamura S
J Hypertens; 1994 Feb; 12(2):137-44. PubMed ID: 8021464
[TBL] [Abstract][Full Text] [Related]
13. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
Nishikibe M; Fukuroda T; Nakajima A
Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
[TBL] [Abstract][Full Text] [Related]
14. Effects of benidipine hydrochloride on contractions induced by some contractile agents in isolated cerebral and mesenteric arteries of dogs.
Suzuki S; Uegomori T; Ozaki S; Takata Y; Kato H
Biol Pharm Bull; 1995 Apr; 18(4):507-13. PubMed ID: 7655417
[TBL] [Abstract][Full Text] [Related]
15. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcium entry blockers on KCl- and 5-hydroxytryptamine-induced contractions of human umbilical arteries.
Salom JB; Campos V; Perales A; Torregrosa G; Miranda FJ; Alabadi JA; Alborch E
Arch Int Pharmacodyn Ther; 1990; 304():219-31. PubMed ID: 2241413
[TBL] [Abstract][Full Text] [Related]
17. Different susceptibility of vasodilator nerve, endothelium and smooth muscle functions to Ca++ antagonists in cerebral arteries.
Toda N; Okamura T
J Pharmacol Exp Ther; 1992 Apr; 261(1):234-9. PubMed ID: 1560370
[TBL] [Abstract][Full Text] [Related]
18. Role of endothelium in regulation of smooth muscle membrane potential and tone in the rabbit middle cerebral artery.
Yamakawa N; Ohhashi M; Waga S; Itoh T
Br J Pharmacol; 1997 Aug; 121(7):1315-22. PubMed ID: 9257909
[TBL] [Abstract][Full Text] [Related]
19. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
[TBL] [Abstract][Full Text] [Related]
20. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
